Skip to main content

Table 1 Patient demographics

From: Intrauterine lidocaine and naproxen for analgesia during intrauterine device insertion: randomized controlled trial

Characteristic

Lidocaine/Naproxen (n = 39)

Lidocaine/Placebo (n = 39)

Saline/Naproxen (n = 40)

Saline/Placebo (n = 39)

P

Age (y)

31.1 ± 8.5

31.1 ± 7.4

31.2 ± 6.5

29.7 ± 6.9

0.788

BMI (kg/m2)

27.6 ± 6.4

26.0 ± 4.1

27.1 ± 5.1

25.9 ± 4.4

0.340

Parity

    

0.510

 Nulliparous

13 (33.3)

17 (43.6)

11 (27.5)

14 (35.9)

 

 Parous

26 (66.7)

22 (56.4)

29 (72.5)

25 (64.1)

 

 Vaginal parity

18 (46.1)

15 (38.4)

12 (30.0)

14 (35.9)

0.408

 Prior c-section

10 (25.6)

9 (23.1)

20 (50.0)

14 (35.9)

0.031

Prior IUD insertion

    

0.605

 Yes

6 (15.4)

9 (23.0)

12 (30.0)

8 (20.5)

 

 No

33 (84.6)

30 (76.9)

28 (70.0)

31 (79.5)

 

Prior Cervical procedures

    

0.298

 Yes

5 (12.5)

12 (30)

6 (15)

6 (15.4)

 

 No

34 (85)

27 (67.5)

34 (85)

33 (84.6)

 

Ease of insertion

    

0.99

 Easy

38 (97.4)

38 (97.4)

38 (95)

36 (94.7)

 

 Difficult

1 (2.6)

1 (2.6)

2 (0.5)

2 (5.2)

 
  1. Data are n%, unless otherwise specified
  2. BMI body mass index, IUD intrauterine device